MSB 2.51% 97.0¢ mesoblast limited

banter and General Discussion, page-9855

  1. 5,714 Posts.
    lightbulb Created with Sketch. 2057
    You asked.... I am fairly pessimistic...

    Do we finish the quarter with
    (a) Refiled BLA - Yes
    (b) Agreed potency assay aka validated for Ryoncil- Won't get definitive answer until BLA approval
    (c) Agreed potency assay aka validated for Revascor - This has been shrouded in mystery...
    (d) Royalty stream partnership for Ryoncil in GvHD ,if approved - well, yes, if approved, but not until then. I also see a partnership for taking Ryoncil international.
    (e) US CLBP partnership and first patient dosed - Nope
    (f) First patient dosed no mention of partners - Yes

    The big question on my mind is whether FDA will give us a 2 month review.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.